Top DoD medicinal and botanical manufacturing contractors (NAICS 325411)
- Latest 12 months
- $3.4B
- Net obligations · Down $1.6B vs. $5.0B preceding
- Prime contractors
- 52
- With positive obligations in the latest 12 months
Research the DoD federal contracting market for medicinal and botanical manufacturing under NAICS 325411. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and observed contract vehicle usage.
Contract obligation trends for Medicinal and Botanical Manufacturing at the Department of Defense
Federal records show $18.9B in net obligations across 710,858 awards in Medicinal and Botanical Manufacturing at the Department of Defense from Oct 1, 2021 through Sep 10, 2026. This market accounts for 0.84% of $2.3T in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 32.2% from $5.0B to $3.4B. 1 prime contractor accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY26 is year-to-date through Sep 10, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $3.4B | 176,168 | Complete |
| FY2023 | $3.3B | 166,232 | Complete |
| FY2024 | $4.2B | 173,217 | Complete |
| FY2025 | $5.0B | 120,738 | Complete |
| FY2026 | $3.1B | 75,749 | YTD through Sep 10, 2026 |
Market at a glance
All reported prime contract awards- All-period net obligations
- $18.9B
- 710,858 awards · 97 prime contractors
- Latest 12-month movement
- −32.2%
- $3.4B vs. $5.0B
- Leading eight prime share
- 99.9%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 0.84% of $2.3T in agency-wide net obligations.
- Set-aside share when reported
- 1.6% of 1,703 awards with reported set-aside status.
- Set-aside reporting
- 27 set aside · 1,676 no set-aside · 709,155 not reported
What changed in the last 12 months?
Sep 11, 2025–Sep 10, 2026, compared with Sep 11, 2024–Sep 10, 2025.
Competitive shifts
Buyer demand
Reported obligations through DLA TROOP SUPPORT decreased
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Federal contract obligations by funding office
See how positive obligations were attributed across funding offices in the 12 months ending Sep 10, 2026.
96.3% of positive obligations were attributed to DLA TROOP SUPPORT (SPE2D8). That represents $3.2B, down $1.5B from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- DLA TROOP SUPPORT (SPE2D8)96.3% · $3.2B · down $1.5B
- DLA TROOP SUPPORT (SPE2DR)2.3% · $78.3M · up $78.3M
- W6DZ CPE CBRND FT DETRICK0.64% · $21.5M · up $732K
- DLA TROOP SUPPORT (SPE2D3)0.23% · $7.9M · down $1.9M
- DLA TROOP SUPPORT (SPE2DX)0.20% · $6.8M · down $151.7M
- All other reported offices0.28% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
DLA TROOP SUPPORT (SPE2D8)
#1Rank unchangedLatest 12 months
$3.2B
96.3% of positive obligations
Versus preceding 12 months
−$1.5B
1 active prime contractor · 50,381 awards
View office comparison and evidence
Reported obligations decreased 32.0% from $4.8B to $3.2B. The office’s share of positive obligations moved from 96.0% to 96.3%, a change of +0.3 percentage points.
The latest period contains 50,381 actions across 50,381 awards. The preceding period contained 1 active prime contractor and 75,495 awards.
Leading award-level changes
- AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F1G47+$5.2M: $0 → $5.2M
- AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F0DPT+$4.9M: $0 → $4.9M
Reported funding office
DLA TROOP SUPPORT (SPE2DR)
#2New to the positive-obligation rankingLatest 12 months
$78.3M
2.3% of positive obligations
Versus preceding 12 months
+$78.3M
2 active prime contractors · 18,878 awards
View office comparison and evidence
Reported obligations rose from $0 to $78.3M. The office’s share of positive obligations moved from 0% to 2.3%, a change of +2.3 percentage points.
The latest period contains 18,878 actions across 18,878 awards and 2 newly active prime contractors. The preceding period contained 0 active prime contractors and 0 awards.
Leading award-level changes
- AMERISOURCEBERGEN DRUG CORP · PIID SPE2DR26FAWEP+$396K: $0 → $396K
- AMERISOURCEBERGEN DRUG CORP · PIID SPE2DR26FAXKF+$355K: $0 → $355K
Reported funding office
W6DZ CPE CBRND FT DETRICK
#3Rank unchangedLatest 12 months
$21.5M
0.64% of positive obligations
Versus preceding 12 months
+$732K
1 active prime contractor · 2 awards
View office comparison and evidence
Reported obligations increased 3.5% from $20.8M to $21.5M. The office’s share of positive obligations moved from 0.42% to 0.64%, a change of +0.2 percentage points.
The latest period contains 4 actions across 2 awards. The preceding period contained 1 active prime contractor and 1 award.
Reported funding office
DLA TROOP SUPPORT (SPE2D3)
#4Rank unchangedLatest 12 months
$7.9M
0.23% of positive obligations
Versus preceding 12 months
−$1.9M
29 active prime contractors · 5,902 awards
View office comparison and evidence
Reported obligations decreased 19.4% from $9.8M to $7.9M. The office’s share of positive obligations moved from 0.20% to 0.23%, a change of 0.0 percentage points.
The latest period contains 5,902 actions across 5,902 awards. The preceding period contained 32 active prime contractors and 8,640 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2DX)
#5Down 3 from #2Latest 12 months
$6.8M
0.20% of positive obligations
Versus preceding 12 months
−$151.7M
2 active prime contractors · 1,697 awards
View office comparison and evidence
Reported obligations decreased 95.7% from $158.5M to $6.8M. The office’s share of positive obligations moved from 3.2% to 0.20%, a change of −3.0 percentage points.
The latest period contains 1,722 actions across 1,697 awards. The preceding period contained 3 active prime contractors and 36,826 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2DU)
#6Up 2 from #8Latest 12 months
$4.7M
0.14% of positive obligations
Versus preceding 12 months
+$4.0M
3 active prime contractors · 2,690 awards
View office comparison and evidence
Reported obligations increased 577.3% from $694K to $4.7M. The office’s share of positive obligations moved from 0.010% to 0.14%, a change of +0.1 percentage points.
The latest period contains 2,690 actions across 2,690 awards and 1 newly active prime contractor. The preceding period contained 2 active prime contractors and 577 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2D0)
#7Down 2 from #5Latest 12 months
$2.7M
0.080% of positive obligations
Versus preceding 12 months
−$3.3M
24 active prime contractors · 227 awards
View office comparison and evidence
Reported obligations decreased 55.2% from $6.0M to $2.7M. The office’s share of positive obligations moved from 0.12% to 0.080%, a change of 0.0 percentage points.
The latest period contains 236 actions across 227 awards and 3 newly active prime contractors. The preceding period contained 30 active prime contractors and 331 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2D2)
#8Up 2 from #10Latest 12 months
$558K
0.020% of positive obligations
Versus preceding 12 months
+$533K
1 active prime contractor · 2,197 awards
View office comparison and evidence
Reported obligations increased 2112.4% from $25K to $558K. The office’s share of positive obligations moved from 0% to 0.020%, a change of 0.0 percentage points.
The latest period contains 2,197 actions across 2,197 awards. The preceding period contained 1 active prime contractor and 1 award.
Reported funding office
DLA TROOP SUPPORT (SPE2DP)
#9Down 3 from #6Latest 12 months
$462K
0.010% of positive obligations
Versus preceding 12 months
−$504K
15 active prime contractors · 201 awards
View office comparison and evidence
Reported obligations decreased 52.2% from $966K to $462K. The office’s share of positive obligations moved from 0.020% to 0.010%, a change of 0.0 percentage points.
The latest period contains 202 actions across 201 awards and 4 newly active prime contractors. The preceding period contained 21 active prime contractors and 669 awards.
Reported funding office
AMC GORDON - PA
#10New to the positive-obligation rankingLatest 12 months
$351K
0.010% of positive obligations
Versus preceding 12 months
+$351K
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations rose from $0 to $351K. The office’s share of positive obligations moved from 0% to 0.010%, a change of 0.0 percentage points.
The latest period contains 2 actions across 1 award and 1 newly active prime contractor. The preceding period contained 0 active prime contractors and 0 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2DB)
#11Down 4 from #7Latest 12 months
$105K
0% of positive obligations
Versus preceding 12 months
−$787K
1 active prime contractor · 63 awards
View office comparison and evidence
Reported obligations decreased 88.3% from $891K to $105K. The office’s share of positive obligations moved from 0.020% to 0%, a change of 0.0 percentage points.
The latest period contains 63 actions across 63 awards. The preceding period contained 2 active prime contractors and 494 awards.
Reported funding office
WALTER REED ARMY INST OF RES - MM
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
+$412K
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations moved from $412K in net deobligations to $0 in net obligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 3 active prime contractors and 3 awards.
Contract types, competition, and procurement methods
From Sep 11, 2025 through Sep 10, 2026, 81,752 awards had positive obligations totaling $3.4B. Negotiated Proposal/Quote was the leading reported procedure, accounting for 99.1% of positive obligations. Awards with a reported parent IDV accounted for 100.0%. Reported awards used contract vehicles such as Medical/Surgical CEC.
- Leading award type
- 100.0%
- Delivery Order
- Leading reported procedure
- 99.1%
- Negotiated Proposal/Quote
- Reported parent IDV
- 100.0%
- of positive obligations had a reported parent IDV
- Median reported offers
- 2
- 204 of 81,752 awards reported offers · Limited reporting
Observed contract vehicles
Only exact reported parent-PIID matches are shown; missing parent IDs are not inferred.
- Medical/Surgical CEC
$3.0M
0.090% of positive obligations · 1,730 matched awards
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 81,548 | $3.4B | 100.0% |
| Purchase Order(B) | 203 | $562K | 0.020% |
| Definitive Contract(D) | 1 | $351K | 0.010% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 81,548 | $3.4B | 100.0% |
| Not reported | 204 | $913K | 0.027% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 81,548 | $3.4B | 100.0% |
| Not reported | 204 | $913K | 0.027% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Negotiated Proposal/Quote(NP) | 80,966 | $3.3B | 99.1% |
| Only One Source(SSS) | 1 | $21.5M | 0.64% |
| Np(NEGOTIATED PROPOSAL/QUOTE) | 581 | $7.9M | 0.24% |
| Simplified Acquisition(SP1) | 201 | $911K | 0.030% |
| Sp1(SIMPLIFIED ACQUISITION) | 3 | $2K | 0% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Full and Open Competition(A) | 80,966 | $3.3B | 99.1% |
| Not Available for Competition(B) | 1 | $21.5M | 0.64% |
| A(FULL AND OPEN COMPETITION) | 581 | $7.9M | 0.24% |
| Competed Under SAP(F) | 171 | $863K | 0.030% |
| Not Competed Under SAP(G) | 30 | $48K | 0% |
| F(COMPETED UNDER SAP) | 2 | $1K | 0% |
| Other reported values | 1 | $413 | <0.0001% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Not reported | 81,752 | $3.4B | 100.0% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 1 | $21.5M | 0.64% |
| SAP Non-Competition (FAR 13)(SP2) | 31 | $48K | 0% |
| Not reported | 81,720 | $3.3B | 99.4% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 81,029 | $3.3B | 99.8% |
| J(FIRM FIXED PRICE) | 584 | $7.9M | 0.24% |
| Fixed Price with Economic Price Adjustment(K) | 139 | $75K | 0% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Drugs and Biologicals(6505) | 72,891 | $3.3B | 98.3% |
| Medical and Surgical Instruments, Equipment, and Supplies(6515) | 8,813 | $56.4M | 1.7% |
| Household Furnishings(7210) | 3 | $21K | 0% |
| Surgical Dressing Materials(6510) | 32 | $20K | 0% |
| Weapons Systems Specific Vehicular Accessories(2541) | 2 | $15K | 0% |
| Hospital and Surgical Clothing and Related Special Purpose Items(6532) | 9 | $8K | 0% |
| Other reported values | 2 | $873 | <0.0001% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Defense Logistics Agency(97AS) | 81,749 | $3.3B | 99.3% |
| Department of the Army(2100) | 2 | $21.9M | 0.65% |
| Department of the Air Force(5700) | 1 | $85K | 0% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Dla Troop Support(SPE2D8) | 50,381 | $3.2B | 96.3% |
| Dla Troop Support(SPE2DR) | 18,686 | $78.3M | 2.3% |
| W6qk Acc-Apg(W911SR) | 1 | $21.5M | 0.64% |
| Dla Troop Support(SPE2D3) | 5,902 | $7.9M | 0.23% |
| Dla Troop Support(SPE2DX) | 1,684 | $6.8M | 0.20% |
| Dla Troop Support(SPE2DU) | 2,690 | $4.7M | 0.14% |
| Other reported values | 2,408 | $4.3M | 0.13% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| SPE2DX22D0020(9700) | 9,070 | $738.3M | 22.0% |
| SPE2DX22D0089(9700) | 4,302 | $524.8M | 15.6% |
| SPE2DX22D0069(9700) | 3,782 | $478.7M | 14.3% |
| SPE2DX22D0049(9700) | 4,089 | $387.8M | 11.6% |
| SPE2DX22D0129(9700) | 3,249 | $342.2M | 10.2% |
| SPE2DX22D0029(9700) | 7,036 | $188.0M | 5.6% |
| SPE2DX22D0099(9700) | 2,514 | $165.6M | 4.9% |
| SPE2DX22D0010(9700) | 5,829 | $127.5M | 3.8% |
| Other reported values | 41,677 | $403.9M | 12.0% |
| Not reported | 204 | $913K | 0.027% |
Exact vehicle-match evidence
- Medical/Surgical CEC
1,730 awards · 8 matched parent PIIDs
Evidence: SPE2D017D0007, SPE2D018D0002, SPE2D019D0008, SPE2D020D0007, SPE2D020D0012, …
$3.0M · 0.090%
Reported award data linked 1,730 awards to a specific catalog vehicle.
Offers, award size, and timing
- Median reported offers
- 2 median
- 204 reported · 81,548 not reported · Limited reporting
- Positive award obligations
- $3K median
- $290–$19K middle 50%
- Reported performance period
- 1 day median
- 81,752 reported · 0 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Sep 10, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Top federal contractors
Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 1 of 52prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 98.7%of positive obligations in the last 12 months
- Leading four prime contractors
- 99.7%of positive obligations in the last 12 months
- Leading eight prime contractors
- 99.9%of positive obligations in the last 12 months
Based on $3.4B in positive obligations during the 12 months ending Sep 10, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Sep 11, 2024–Sep 10, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$3.3B
98.7%
Dollar movement
−$1.6B
vs. prior 12 months
Last 12mo awards
69,491 awards
69,516 actions
Historical and award details for AMERISOURCEBERGEN DRUG CORP
- Obligations: prior → latest
- $4.9B → $3.3B
- −32.4%
- Share: prior → latest
- 98.9% → 98.7%
- −0.2 percentage points
- All-period obligations
- $15.1B
- 79.9% of all-period positive obligations · 563,282 awards
- Recorded activity
- Since Oct 1, 2021
- through Jun 7, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 69,491 106,960 Reported small business 0 0 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$21.5M
0.64%
Dollar movement
+$732K
vs. prior 12 months
Last 12mo awards
2 awards
4 actions
Historical and award details for EMERGENT BIODEFENSE OPERATIONS LANSING LLC
- Obligations: prior → latest
- $20.8M → $21.5M
- +3.5%
- Share: prior → latest
- 0.42% → 0.64%
- +0.2 percentage points
- All-period obligations
- $63.3M
- 0.33% of all-period positive obligations · 2 awards
- Recorded activity
- Since Jan 19, 2024
- through Mar 4, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 2 1 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$10.4M
0.31%
Dollar movement
−$5.2M
vs. prior 12 months
Last 12mo awards
5,682 awards
5,682 actions
Historical and award details for DMS PHARMACEUTICAL GROUP INC
- Obligations: prior → latest
- $15.6M → $10.4M
- −33.3%
- Share: prior → latest
- 0.32% → 0.31%
- 0.0 percentage points
- All-period obligations
- $142.7M
- 0.75% of all-period positive obligations · 46,305 awards
- Recorded activity
- Since Oct 1, 2021
- through Jun 4, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 18 10 Not reported 5,664 5,467 Reported small business 5,681 5,477 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$3.7M
0.11%
Dollar movement
−$1.4M
vs. prior 12 months
Last 12mo awards
1,785 awards
1,785 actions
Historical and award details for CARDINAL HEALTH, INC.
- Obligations: prior → latest
- $5.1M → $3.7M
- −27.1%
- Share: prior → latest
- 0.10% → 0.11%
- 0.0 percentage points
- All-period obligations
- $25.0M
- 0.13% of all-period positive obligations · 11,254 awards
- Recorded activity
- Since Oct 1, 2021
- through May 21, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 1,785 2,114 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$2.5M
0.070%
Dollar movement
+$1000K
vs. prior 12 months
Last 12mo awards
696 awards
696 actions
Historical and award details for ATLANTIC DIVING SUPPLY, INC.
- Obligations: prior → latest
- $1.5M → $2.5M
- +68.4%
- Share: prior → latest
- 0.030% → 0.070%
- 0.0 percentage points
- All-period obligations
- $4.3M
- 0.020% of all-period positive obligations · 2,247 awards
- Recorded activity
- Since Apr 14, 2022
- through Apr 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 696 1,131 Reported small business 696 1,131 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$1.4M
0.040%
Dollar movement
+$301K
vs. prior 12 months
Last 12mo awards
680 awards
680 actions
Historical and award details for ALTITUDE TECHNOLOGIES INC.
- Obligations: prior → latest
- $1.1M → $1.4M
- +26.2%
- Share: prior → latest
- 0.020% → 0.040%
- 0.0 percentage points
- All-period obligations
- $3.4M
- 0.020% of all-period positive obligations · 2,366 awards
- Recorded activity
- Since Oct 1, 2021
- through May 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 680 772 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$839K
0.020%
Dollar movement
+$461K
vs. prior 12 months
Last 12mo awards
206 awards
206 actions
Historical and award details for CHARTWELL RX LLC
- Obligations: prior → latest
- $378K → $839K
- +121.7%
- Share: prior → latest
- 0.010% → 0.020%
- 0.0 percentage points
- All-period obligations
- $2.9M
- 0.020% of all-period positive obligations · 735 awards
- Recorded activity
- Since Oct 27, 2021
- through Apr 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 206 160 Reported small business 206 160 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$699K
0.020%
Dollar movement
−$744K
vs. prior 12 months
Last 12mo awards
625 awards
631 actions
Historical and award details for PHOENIX TEXTILE CORPORATION
- Obligations: prior → latest
- $1.4M → $699K
- −51.6%
- Share: prior → latest
- 0.030% → 0.020%
- 0.0 percentage points
- All-period obligations
- $8.7M
- 0.050% of all-period positive obligations · 6,225 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 625 1,203 Reported small business 146 207 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$553K
0.020%
Dollar movement
−$228K
vs. prior 12 months
Last 12mo awards
299 awards
299 actions
Historical and award details for JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC.
- Obligations: prior → latest
- $782K → $553K
- −29.2%
- Share: prior → latest
- 0.020% → 0.020%
- 0.0 percentage points
- All-period obligations
- $3.3M
- 0.020% of all-period positive obligations · 1,979 awards
- Recorded activity
- Since Oct 4, 2021
- through Apr 23, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 299 611 Reported small business 0 0 All-period set-aside types
None reported.
- #10
Last 12mo obligations
$467K
0.010%
Dollar movement
+$136K
vs. prior 12 months
Last 12mo awards
269 awards
269 actions
Historical and award details for SKLAR CORPORATION
- Obligations: prior → latest
- $330K → $467K
- +41.2%
- Share: prior → latest
- 0.010% → 0.010%
- 0.0 percentage points
- All-period obligations
- $2.5M
- 0.010% of all-period positive obligations · 1,416 awards
- Recorded activity
- Since Oct 8, 2021
- through May 6, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 269 452 Reported small business 269 452 All-period set-aside types
None reported.
- #11
Last 12mo obligations
$464K
0.010%
Dollar movement
−$29K
vs. prior 12 months
Last 12mo awards
10 awards
10 actions
Historical and award details for CERA PRODUCTS, INC.
- Obligations: prior → latest
- $493K → $464K
- −5.9%
- Share: prior → latest
- 0.010% → 0.010%
- 0.0 percentage points
- All-period obligations
- $1.9M
- 0.010% of all-period positive obligations · 113 awards
- Recorded activity
- Since Jan 31, 2022
- through Apr 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 10 39 Reported small business 10 39 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$432K
0.010%
Dollar movement
−$2.3M
vs. prior 12 months
Last 12mo awards
544 awards
544 actions
Historical and award details for FRESENIUS KABI, LLC
- Obligations: prior → latest
- $2.7M → $432K
- −83.9%
- Share: prior → latest
- 0.050% → 0.010%
- 0.0 percentage points
- All-period obligations
- $7.7M
- 0.040% of all-period positive obligations · 2,519 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 544 483 Reported small business 0 0 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$351K
0.010%
Dollar movement
−$88K
vs. prior 12 months
Last 12mo awards
1 award
3 actions
Historical and award details for CARDINAL HEALTH 414, LLC
- Obligations: prior → latest
- $438K → $351K
- −20.0%
- Share: prior → latest
- 0.010% → 0.010%
- 0.0 percentage points
- All-period obligations
- $1.8M
- 0.010% of all-period positive obligations · 1 award
- Recorded activity
- Since Nov 17, 2021
- through Mar 25, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$231K
0.010%
Dollar movement
−$41K
vs. prior 12 months
Last 12mo awards
151 awards
151 actions
Historical and award details for COMBAT MEDICAL SYSTEMS LLC
- Obligations: prior → latest
- $273K → $231K
- −15.2%
- Share: prior → latest
- 0.010% → 0.010%
- 0.0 percentage points
- All-period obligations
- $2.3M
- 0.010% of all-period positive obligations · 2,054 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 23, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 151 79 Reported small business 151 79 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$203K
0.010%
Dollar movement
−$90K
vs. prior 12 months
Last 12mo awards
3 awards
3 actions
Historical and award details for EAGLE PHARMACEUTICALS, INC.
- Obligations: prior → latest
- $293K → $203K
- −30.7%
- Share: prior → latest
- 0.010% → 0.010%
- 0.0 percentage points
- All-period obligations
- $1.4M
- 0.010% of all-period positive obligations · 111 awards
- Recorded activity
- Since Oct 15, 2021
- through Feb 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 3 18 Reported small business 3 18 All-period set-aside types
None reported.
Recent federal contract award activity
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
+$5.2M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570863919!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.15% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $1.6B overall.
- Award net obligations
- $5.2M
- Share of 12-month positive obligations
- 0.15%
Supporting data
- Prime contractor
- #1 · 98.7% share
- $1.6B net decline despite this positive action
- Funding office
- #1 · 96.3% attributed share
- $1.5B net decline despite this positive action
This action
+$4.9M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570703411!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.15% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $1.6B overall.
- Award net obligations
- $4.9M
- Share of 12-month positive obligations
- 0.15%
Supporting data
- Prime contractor
- #1 · 98.7% share
- $1.6B net decline despite this positive action
- Funding office
- #1 · 96.3% attributed share
- $1.5B net decline despite this positive action
This action
+$4.8M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570863839!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.14% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $1.6B overall.
- Award net obligations
- $4.8M
- Share of 12-month positive obligations
- 0.14%
Supporting data
- Prime contractor
- #1 · 98.7% share
- $1.6B net decline despite this positive action
- Funding office
- #1 · 96.3% attributed share
- $1.5B net decline despite this positive action
This action
+$4.3M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570677280!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.13% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $1.6B overall.
- Award net obligations
- $4.3M
- Share of 12-month positive obligations
- 0.13%
Supporting data
- Prime contractor
- #1 · 98.7% share
- $1.6B net decline despite this positive action
- Funding office
- #1 · 96.3% attributed share
- $1.5B net decline despite this positive action
This action
+$4.2M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570703216!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.13% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $1.6B overall.
- Award net obligations
- $4.2M
- Share of 12-month positive obligations
- 0.13%
Supporting data
- Prime contractor
- #1 · 98.7% share
- $1.6B net decline despite this positive action
- Funding office
- #1 · 96.3% attributed share
- $1.5B net decline despite this positive action
This action
+$4.0M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570703403!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.12% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $1.6B overall.
- Award net obligations
- $4.0M
- Share of 12-month positive obligations
- 0.12%
Supporting data
- Prime contractor
- #1 · 98.7% share
- $1.6B net decline despite this positive action
- Funding office
- #1 · 96.3% attributed share
- $1.5B net decline despite this positive action
View recent award activity by date (10)
- Action+$14KAward net obligations$14K
- Action+$8KAward net obligations$8K
- Action+$3KAward net obligations$3K
- Action+$5KAward net obligations$5K
- Action+$1KAward net obligations$1K
- Action+$291Award net obligations$291
- Action+$11Award net obligations$11
- Action+$1KAward net obligations$1K
- Action+$122KAward net obligations$122K
- Action+$3KAward net obligations$3K
DoD medicinal and botanical manufacturing market FAQs
Answers based on reported federal contract data.
Who are the top DoD medicinal and botanical manufacturing contractors?
In the 12 months through September 10, 2026, AMERISOURCEBERGEN DRUG CORP, EMERGENT BIODEFENSE OPERATIONS LANSING LLC, and DMS PHARMACEUTICAL GROUP INC were the leading DoD medicinal and botanical manufacturing prime contractors by positive obligations.
- #1
$3,312,221,276 in positive obligations
- #2
EMERGENT BIODEFENSE OPERATIONS LANSING LLC
$21,534,000 in positive obligations
- #3
$10,429,095 in positive obligations
Rankings use reported USAspending award data.
Did DoD contract obligations decrease in the medicinal and botanical manufacturing market?
Yes. Measured by net prime contract obligations, reported DoD activity in the medicinal and botanical manufacturing market decreased 32.2% from $4,953,303,920 in the preceding 12 months to $3,357,687,848 in the 12 months through September 10, 2026.
- Latest 12 months
- $3,357,687,848
- Net prime contract obligations
- Preceding 12 months
- $4,953,303,920
- Net prime contract obligations
- Change
- −32.2%
- Between matched 12-month periods
Reported contract actions, not outlays or a forecast.
What recent DoD contract award activity was reported in the medicinal and botanical manufacturing market?
Recent DoD contract award activity reported in the medicinal and botanical manufacturing market included actions for AMERISOURCEBERGEN DRUG CORP during the 12 months through September 10, 2026.
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F1G47
Base award · February 18, 2026 · Action obligation: +$5,177,536
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F0DPT
Base award · February 3, 2026 · Action obligation: +$4,925,174
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F10Z9
Base award · February 18, 2026 · Action obligation: +$4,787,164
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F09G3
Base award · February 2, 2026 · Action obligation: +$4,342,424
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F1C24
Base award · February 3, 2026 · Action obligation: +$4,202,486
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F09V0
Base award · February 3, 2026 · Action obligation: +$4,030,125
Action obligations are transaction-level amounts, not current award-level obligations.
Which procurement methods were reported for DoD contracts under NAICS 325411?
From September 11, 2025 through September 10, 2026, DoD reported 81,752 positive-obligation awards for medicinal and botanical manufacturing under NAICS 325411. The leading award type was delivery order. The leading reported procedure was negotiated proposal/quote.
- Positive-obligation awards
- 81,752
- Leading reported procedure
- Negotiated Proposal/Quote
- 99.1% of positive obligations
- Leading award type
- Delivery Order
- 100% of positive obligations
- Full and open
- 99.1%
- of positive obligations
- Reported parent IDV
- 100%
- of positive obligations
Percentages use positive obligations as the denominator.
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Leading-prime vehicle memberships:
Company memberships do not establish award-channel use.Reported obligations include contract actions from October 1, 2021 through September 10, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility. Public Department of Defense award records are generally delayed by 90 days.
Review data methodology